200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 77269-31-9
77269-31-9 | Methanimidic acid, N-hydroxy-, (E)-
CAS No: 77269-31-9 Catalog No: AG005D2Z MDL No:
Product Description
Catalog Number:
AG005D2Z
Chemical Name:
Methanimidic acid, N-hydroxy-, (E)-
CAS Number:
77269-31-9
Molecular Formula:
CH3NO2
Molecular Weight:
61.0400
IUPAC Name:
N-hydroxyformamide
InChI:
InChI=1S/CH3NO2/c3-1-2-4/h1,4H,(H,2,3)
InChI Key:
KDGKTJGPFXIBEB-UHFFFAOYSA-N
SMILES:
O/N=C/O
NSC Number:
101638
Properties
Complexity:
20
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
61.016g/mol
Formal Charge:
0
Heavy Atom Count:
4
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
61.04g/mol
Monoisotopic Mass:
61.016g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
49.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.9
Literature
| Title | Journal |
|---|---|
| A hydrogen-bridged adduct 3,4,6,7,8,9-hexa-hydro-2H-pyrimido[1,2-a]pyrimidin-1-ium [1,3-bis-(tert-butyl-dimethyl-sil-yloxy)-1,3-bis-(pyridin-2-yl)propan-2-yl-idene]nitro-nate acetonitrile monosolvate. | Acta crystallographica. Section E, Structure reports online 20110901 |
| Effect of alkyl substitution on H-bond strength of substituted amide-alcohol complexes. | Journal of molecular modeling 20110701 |
| Peptidomimetic inhibitors of bacterial peptide deformylase. | Bioorganic & medicinal chemistry letters 20110701 |
| Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis. | Bioorganic & medicinal chemistry letters 20110601 |
| The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis. | Bioorganic & medicinal chemistry letters 20110301 |
| Expanding stereochemical and skeletal diversity using petasis reactions and 1,3-dipolar cycloadditions. | Organic letters 20101119 |
| Long-range migration of a water molecule to catalyze a tautomerization in photoionization of the hydrated formamide cluster. | The journal of physical chemistry. A 20101111 |
| A medicinal chemist's guide to molecular interactions. | Journal of medicinal chemistry 20100722 |
| Medicinal chemistry of 2,2,4-substituted morpholines. | Current medicinal chemistry 20100101 |
| Bifid mandibular condyle: Report of two cases of varied etiology. | National journal of maxillofacial surgery 20100101 |
| Relative Comparison of Catalytic Characteristics of Human Foamy Virus and HIV-1 Integrases. | Acta naturae 20090701 |
| 4,4'-(Anthracene-9,10-di-yl)dibenzoic acid dimethyl-formamide disolvate. | Acta crystallographica. Section E, Structure reports online 20090601 |
| Size-selected infrared predissociation spectroscopy of neutral and cationic formamide-water clusters: stepwise growth of hydrated structures and intracluster hydrogen transfer induced by vacuum-ultraviolet photoionization. | The journal of physical chemistry. A 20080731 |
| Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. | Current pharmaceutical design 20080101 |
| Drug forecast - the peptide deformylase inhibitors as antibacterial agents. | Therapeutics and clinical risk management 20070801 |
| Ab initio molecular dynamics study of the hydration of the formohydroxamate anion. | Biophysical chemistry 20061201 |
| Computational study of structural and dynamical properties of formamide-water mixtures. | The Journal of chemical physics 20061114 |
| Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets. | Biophysical chemistry 20060620 |
| Bacterial siderophores: the solution stoichiometry and coordination of the Fe(III) complexes of pyochelin and related compounds. | Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20060601 |
| L-prolinamide-catalyzed direct nitroso aldol reactions of alpha-branched aldehydes: a distinct regioselectivity from that with L-proline. | Chemical communications (Cambridge, England) 20060128 |
| PDF inhibitors: an emerging class of antibacterial drugs. | Current drug targets. Infectious disorders 20050301 |
| Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents. | Current medicinal chemistry 20050101 |
| Highly stereoselective grignard addition to cis-substituted C-cyclopropylaldonitrones. The bisected s-trans transition state can be stabilized effectively by the Lewis acid-coordination. | The Journal of organic chemistry 20041224 |
| Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group. | Bioorganic & medicinal chemistry letters 20040119 |
| Structure-based design of a macrocyclic inhibitor for peptide deformylase. | Journal of medicinal chemistry 20030828 |
| Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chain. | Bioorganic & medicinal chemistry letters 20030818 |
| CYP3A induction by N-hydroxyformamide tumor necrosis factor-alpha converting enzyme/matrix metalloproteinase inhibitors use of a pregname X receptor activation assay and primary hepatocyte culture for assessing induction potential in humans. | Drug metabolism and disposition: the biological fate of chemicals 20030701 |
| Structural basis of fosmidomycin action revealed by the complex with 2-C-methyl-D-erythritol 4-phosphate synthase (IspC). Implications for the catalytic mechanism and anti-malaria drug development. | The Journal of biological chemistry 20030516 |
| Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group. | Bioorganic & medicinal chemistry letters 20021216 |
| Thermodynamics and micellar properties of tetradecyltrimethylammonium bromide in formamide-water mixtures. | Journal of colloid and interface science 20021115 |
| Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). | Journal of medicinal chemistry 20011122 |
| Catalytic mechanism of glyoxalase I: a theoretical study. | Journal of the American Chemical Society 20011024 |
| Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor. | Bioorganic & medicinal chemistry letters 20011008 |
| Modeling the 1,3-dipolar cycloaddition of nitrones to vinylboranes in competition with boration, cyclization, and oxidation reactions. | The Journal of organic chemistry 20010406 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.